Skip to content
Independent analysis for capital decisions
Wert-Berater Financial

Wert-Berater Financial · Americas

Market Intelligence for Healthcare Development in Costa Rica

Working paper draft for market intelligence: Costa Rica healthcare development. This draft separates export medical devices from clinical services and medical tourism, and it treats each as a distinct market with its own buyer, capacity constraint, payer logic, and evidence base. It is analytical only and requires project-specific verification before use.

English editionApproved for publication by Wert-Berater Financial.

Dated evidence for the markets discussed

World Bank WDI source update and observation years are retained below. Checked 2026-11-22. The method that follows does not infer project demand from these national observations or report unperformed fieldwork.

Reported annual macroeconomic observations—not project demand or a forecast. Each value retains its own year; unlike-year observations must not be ranked or summed.
CountryPopulationGDP (current USD)Real GDP growth (annual %)CPI inflation (annual %)
Costa Rica5,152,950 (2025)102,904,921,157.48 (2025)4.56 (2025)-0.07 (2025)
Scroll horizontally to see the full table

Scope and classification

The first task is to classify the project correctly before any market sizing is attempted. A medical-device export thesis depends on manufacturing output, supplier inputs, logistics, and external buyers. A clinical-services thesis depends on patient demand, payer mix, referral flow, staffing, equipment, and bed or chair capacity. A medical-tourism thesis depends on origin markets, travel access, procedure selection, companion behavior, length of stay, and post-treatment follow-up.

The workpaper should state the service line in plain language, identify the payer, identify the referral channel, and define the catchment area. If the project is a hospital or clinic, the catchment should be built from realistic travel times, competing facilities, patient willingness to travel, and the procedures actually offered. If the project is manufacturing, the relevant market is not local patient demand but export demand, supplier concentration, and production throughput.

Do not merge these markets. A facility that exports devices may not be able to support domestic clinical utilization, and a clinic serving local patients may have no relevance to device export volumes. The conclusion must therefore be written separately for each line of business, even if the same corporate sponsor is involved.

  • Required records: project description, legal entity chart, site plan, equipment list, staffing plan, service catalog, payer contracts or draft term sheets, referral agreements if any, and a written statement of intended patient or buyer segments.
  • Reconciliation rule: if the sponsor describes the project as both an export facility and a treatment center, split the analysis into separate workstreams and require separate demand evidence for each.
  • Finding that changes the conclusion: evidence that the facility is not actually providing the service line described, or that the stated payer or referral source does not exist or will not contract, changes the market conclusion materially.

Evidence base and records needed

The evidence base should prioritize records that can be independently checked. For a clinical project, that includes operating licenses where applicable, floor plans, treatment room counts, equipment specifications, staffing rosters, physician schedules, payer policy documents, referral source lists, appointment logs, and historical utilization data if the facility already exists. For a new project, it includes letters of intent, channel pipeline records, recruiting status, procurement quotes, and commissioning milestones.

For a medical-tourism project, the evidence should also include airport access, ground transfer times, hotel inventory near the site, language capability, concierge or case-management arrangements, postoperative accommodation assumptions, and historical patient origin information if available. A simple arrival series is not a patient series and cannot be used as a direct proxy for demand.

For an export-manufacturing project, request production records, bill of materials, quality control records, supplier concentration, order backlog, customer concentration, shipping terms, and any regulatory or customer qualification documents. If the business model depends on imported inputs, request procurement terms and currency clauses for each major input class. Domestic wage and utility assumptions should be separated from foreign-currency revenues and imported equipment costs.

  • Required records: source documents, not summaries, whenever possible; dated contracts; underlying spreadsheets with formulas intact; and any correspondence that explains changes in scope or pricing.
  • Reconciliation rule: compare what management says the project is, what the legal entity is permitted to do, and what the records show it can already do. Any mismatch should be flagged as an assumption, not treated as fact.
  • Finding that changes the conclusion: absence of documentary support for the stated patient flow, equipment readiness, or customer pipeline should reduce confidence in the demand estimate and may invalidate any claim of near-term operating scale.

Reproducible step-by-step method

Step one is to define the unit of analysis. For clinical services, the unit may be consults, procedures, inpatient episodes, room nights, or annual patient journeys. For tourism-linked care, choose one primary unit and keep it consistent through the model. For manufacturing, choose units of output, shipped orders, or contract capacity.

Step two is to construct the supply side. Count usable treatment rooms, operating theaters, recovery spaces, diagnostic assets, and staff shifts that are actually available after maintenance, leave, and credentialing constraints. For manufacturing, count machines, line speeds, setup time, quality checks, and approved shifts. Use verified operating capacity rather than nominal installed capacity.

Step three is to construct demand. For clinical care, demand should come from the intersection of diagnosis mix, referral source, payer approval, price sensitivity, travel burden, and competitor availability. For medical tourism, demand should be segmented by procedure type and origin market, then constrained by access, language, package design, and follow-up ability. For exports, demand should be segmented by customer and product line, then constrained by customer qualification and order cadence.

Step four is to build the serviceable market. This is the subset of total demand that the project can realistically reach with its actual location, product set, channel access, and staffing. The serviceable market should not exceed what can be served given the documented capacity and the likely conversion of inquiries or leads into paid utilization.

Step five is to create a paid-utilization range. Use a conservative case, a base case, and a stretch case, but only after each case is tied to a documented assumption set. Each assumption should be traceable to a record, interview, or external series. Where evidence is weak, reduce the assumption rather than smoothing it.

Step six is to write a bridge from demand to revenue. The bridge should show how inquiries become evaluations, evaluations become bookings or admissions, and bookings become revenue. For manufacturing, show how orders become shipments and collections. Every conversion assumption must be stated and tested against the records.

Step seven is to test sensitivity. Identify the one or two variables that change the outcome most, usually utilization, average revenue per case or unit, staffing availability, payer acceptance, or equipment uptime. Then test whether the project remains viable if those variables move against the sponsor’s plan.

  • Required records: dated interview notes, management schedules, capacity logs, booking logs, order logs, pricing sheets, payer terms, and a version-controlled assumption file.
  • Reconciliation rule: demand estimates must not exceed the lesser of documented capacity and documented addressable demand once channel frictions are applied.
  • Finding that changes the conclusion: if the modeled utilization requires more staff, more rooms, more referrals, or more qualified customers than the records support, the conclusion should move from feasible to unproven or not supported.

Verification and triangulation

No single source should carry the conclusion. Triangulate each major claim with at least three types of evidence where possible: internal records, interview evidence, and external authoritative statistics or market records. The external series should be used to contextualize the project, not to replace project-level evidence.

For example, a national health or export series may help explain the overall environment, but it cannot prove clinic demand at a specific site or buyer demand for a specific product. A facility may sit in a strong national market and still underperform because of access, staffing, channel weakness, or pricing.

Interview evidence must be treated cautiously. A primary interview can clarify process, but it does not validate volume unless supported by logs or contracts. Statements about expected demand should be checked against realized bookings, waiting lists, transfer records, insurer panels, or customer orders.

Reconcile all discrepancies explicitly. If management says a channel is active but records show no recent conversions, classify the channel as aspirational. If the facility claims a price point but no executed pricing schedule is available, use the last signed tariff or publicly posted price list, not verbal estimates.

  • Required records: interview memos, source documents, external statistical series, and a discrepancy log.
  • Reconciliation rule: where sources conflict, give precedence to dated executed documents over verbal statements, and precedence to observed utilization over planned utilization.
  • Finding that changes the conclusion: unresolved contradictions on capacity, pricing, or customer access should prevent a positive market conclusion.

Downside analysis and adverse cases

The downside analysis should ask what fails first if the market is weaker than expected. For clinical care, common failure points include slow credentialing, weak referral flow, lower payer acceptance, physician recruitment delays, underused equipment, and higher no-show rates. For tourism-linked care, the main risks often include travel friction, longer decision cycles, competitor packages, seasonality, companion costs, and postoperative logistics. For manufacturing, the main risks often include customer concentration, input cost volatility, qualification delays, and lower-than-planned line uptime.

A useful downside case is not simply a smaller version of the base case. It should reflect a different operating reality. For example, the project may open with fewer active referral sources than planned, or with one key specialist missing, or with limited insurance participation. In that case the serviceable market may shrink materially even if headline national demand remains strong.

Currency risk must be separated by contract type. If wages and local overhead are in local currency while revenue is partly in foreign currency, the model should identify who absorbs movements in each contract. If imported equipment or consumables are priced in foreign currency, the analysis should show whether the project has natural hedges, pricing pass-through, or neither. Do not assume that location in a business cluster or special zone automatically offsets currency exposure.

A project-specific downside case should also examine commissioning delays. If opening is delayed, staffing, preopening costs, and customer acquisition timing shift together. The workpaper should therefore test whether the project remains credible if commissioning takes longer than planned or if utilization ramps more slowly than management expects.

  • Required records: staffing recruitment status, vendor lead times, currency clauses, insurance panel status, referral commitments, and commissioning schedule.
  • Reconciliation rule: downside assumptions should be linked to the weakest documented link in the delivery chain, not to a generic macro slowdown.
  • Finding that changes the conclusion: if the downside case makes the project unable to reach break-even service volume or customer acceptance within a realistic operating period, the project should be treated as high risk until evidence improves.

Investigation stop conditions

The investigation should stop expanding once additional effort is unlikely to change the recommendation. That occurs when the core questions have been answered by records rather than by opinion: what service line exists, who pays, who refers, what capacity exists, what prices are actually charged, what utilization can be supported, and what the main downside is.

Stop collecting new interviews when they begin to repeat the same uncorroborated assertions. Stop expanding the scope when the project owner cannot provide basic documents after reasonable requests, because absent records are themselves a risk signal. Stop market extrapolation when the project-specific serviceable market is already constrained by hard capacity or channel limits that cannot be materially changed in the near term.

A separate stop condition applies to claims of incentive eligibility or special treatment. If eligibility depends on factual status not yet documented, pause that element and classify it as unverified rather than assumed. The analysis should not substitute location branding for proof of qualification.

The workpaper is complete when further information would only refine the estimate rather than change the decision branch. At that point, record what remains uncertain, but do not delay the conclusion for marginal precision gains.

  • Required records: document request tracker, missing-item list, and a note of repeated unanswered questions.
  • Reconciliation rule: unresolved core-document gaps should be preserved as limitations, not silently filled with assumptions.
  • Finding that changes the conclusion: if the missing documents relate to payer access, legal operating scope, or actual capacity, the investigation should remain open until those gaps are closed or the conclusion should be downgraded.

Limitations and interpretation discipline

This workpaper is limited by the quality of the source records and by the fact that market intelligence is not the same as operating proof. A strong national context does not guarantee a successful local project. Similarly, a strong interview narrative does not replace executed contracts, utilization logs, or purchase orders.

The analysis also has a structural limitation in that demand for healthcare services is often fragmented by specialty, payer, and geography. A national headline can conceal a weak subsegment, and a subsegment can be strong even when the national average is flat. That is why the conclusion must be tied to the exact service line and channel, not to the country in general.

Where data are incomplete, the proper response is not to force precision. Use ranges, identify the assumption that drives each range, and label the result as contingent on the missing evidence. Avoid turning a screening memo into a definitive market study when the records do not support that leap.

  • Required records: a limitations log tied to each major assumption.
  • Reconciliation rule: every unsupported statement should be labeled as an assumption, estimate, or management assertion, never as a verified fact.
  • Finding that changes the conclusion: if a key assumption cannot be independently checked and it materially affects volume or pricing, the project should be reported as unconfirmed rather than supported.

Decision workpaper and conclusion logic

The final workpaper should answer three questions in one page of decision logic. First, what exactly is being sold or delivered. Second, who is the payer or buyer and through which channel does business arrive. Third, what verified capacity and utilization can the project realistically support. The answer should be written separately for device exports, clinical services, and medical tourism if more than one is present.

A supportable conclusion exists only if the serviceable market is bounded by verified evidence and if the paid-utilization range can be traced to real channels, real capacity, and real pricing. If the records show a mismatch between intended scope and actual operating capability, the conclusion should state that the market opportunity is not yet demonstrated rather than overstating the case.

The decision language should be conditional. For example: if the documented payer channels, staffing plan, and equipment readiness are confirmed, the project may justify further diligence on commercial terms. If the records do not support those items, the project should be treated as unproven. This formulation avoids legal conclusions and avoids implying investment advice.

Every decision memo should end with the single finding that would change the conclusion. That finding might be a signed payer contract, confirmed referral pathway, validated operating capacity, or a documented customer order base. Until that evidence exists, the workpaper should remain cautious and project-specific.

  • Required records: all prior sections assembled into one decision file with source references and unresolved issues.
  • Reconciliation rule: the decision statement must be consistent with the weakest verified link in the chain from demand to revenue.
  • Finding that changes the conclusion: one credible, dated document that confirms the central commercial assumption can move the conclusion; one credible document that disproves it should move it in the opposite direction.

Scope, provenance and professional limitations

Wert-Berater Financial provides independent analytical decision support. We do not provide or arrange financing, broker securities, solicit investments or guarantee returns. Every engagement is subject to scope, data availability, geographic coverage, professional qualifications, applicable local law, regulatory restrictions, sanctions, counterparty and payment-risk review. Market coverage does not imply a local office, licence, professional designation or partnership. Local legal, tax, engineering and regulated professional conclusions require appropriately qualified advisers.

Questions

How should medical-device exports be treated in this assignment?

As an industrial export question, not as patient demand. The analysis should use production capacity, supplier inputs, customer qualification, and shipment records, while keeping local healthcare utilization separate unless the project explicitly includes a domestic service line.

Can airport arrivals be used as a proxy for medical patients?

Not directly. Arrivals can help frame travel context, but they do not establish that travelers became patients, chose the project’s facility, or purchased the relevant procedure. Patient counts require booking, admission, or treatment records.

What is the most important reconciliation step?

Reconcile the sponsor narrative with the documents. If the project is described as a clinic, hospital, or tourism service, confirm that the legal permissions, staffing, equipment, and payer or referral records support that description.

What kind of finding would change the conclusion most quickly?

A dated, credible document that confirms or disproves the central commercial assumption, such as payer access, referral flow, actual capacity, or signed customer demand. That finding should override weaker interview claims.

Research

Sources

  1. World Bank WDI: Population (persons)Updated 2026-11-11 · Checked 2026-11-22
  2. World Bank WDI: GDP (current USD)Updated 2026-11-11 · Checked 2026-11-22
  3. World Bank WDI: Real GDP growth (annual %)Updated 2026-11-11 · Checked 2026-11-22
  4. World Bank WDI: Consumer-price inflation (annual %)Updated 2026-11-11 · Checked 2026-11-22
  5. Costa Rica: official statistics and project-research starting point
  6. Costa Rica: monetary, financial or qualification reference

Start a conversation

Define the question.
Scope the analysis.

Scope, reliance, deliverables, fees and timing are confirmed only in a written engagement. Submitting this form does not create one.

You
The project
Preferences and consent

Translation assistant

Machine translation between English and Spanish, Portuguese, French or Dutch. Output is not human reviewed and must not be relied on for legal or contractual meaning.

Engagements Completed
4,000+
SBA Studies Accepted by Lenders
1,300+
USDA Studies in Agency Financing
950+
Project Value Evaluated
$43.8B
Feasibility Consultants Since
1998

Thousands of real estate, business, and machinery appraisal and litigation assignments.